Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Mild Dysplastic Nevi: Observation, Not Re-Excision
JAMA Dermatol; ePub 2016 Aug 17; Fleming, et al
In cases of mild and moderate dysplastic nevi (DN) with microscopically positive margins and no concerning clinical residual lesion, observation, rather than re-excision, was a reasonable management option, according to a recent study. Researchers conducted a retrospective cohort study of patients with biopsy-confirmed DN with positive histologic margins. A consecutive sample of 1,473 histologically confirmed DN was identified using surgical pathology databases at the study sites: 590 cases in 498 patients met criteria (mean age, 57.6 years; 90% male). Researchers found:
• Cases in the observation group were more likely to demonstrate nevus recurrence that those that were re-excised (3.3% vs 0%).
• 6 of 304 (2.0%) observed DN subsequently developed melanoma at the same site, compared with 1 of 170 (0.06%) that were re-excised.
• Only 1 care of thin invasive melanoma (≤1 mm) was observed, and no deaths from melanoma arising from biopsy-proven DN occurred through the latest dermatology follow-up.
Fleming NH, Egbert BM, Kim J, Swetter SM. Reexamining threshold for reexcision of histologically transected dysplastic nevi. [Published online ahead of print August 17, 2016]. JAMA Dermatol. doi:10.1001/jamadermatol.2016.2869.
This Week's Must Reads
Must Reads in Dermatopathology
Melanoma Rates Before and After AJCC 7 Enactment, JAMA Dermatol; ePub 2019 Mar 6; Isom, et al
Melanoma Risk and Moderately Dysplastic Nevi, JAMA Dermatol; ePub Oct 10; Kim, Berry, et al